High income vs Luxembourg: Immunization, Hib3
High income
93.2%
in 2024
Luxembourg
99.0%
in 2024
High income rank
4th
Luxembourg rank
1st
Immunization, Hib3 over time
- High income
- Luxembourg
How they compare
Luxembourg currently reports 99.0% against 93.2% in High income, a difference of 5.8%.
That makes Luxembourg's figure about 1.1 times High income's.
Across all 28 years both countries report, Luxembourg has been ahead every year.
High income ranks 4th and Luxembourg ranks 1st of 43 groups.
Luxembourg has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | High income | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 52.3% | 88.3% | 36.0% | Luxembourg |
| 2000s | 68.1% | 97.6% | 29.5% | Luxembourg |
| 2010s | 80.7% | 99.0% | 18.3% | Luxembourg |
| 2020s | 89.1% | 99.0% | 9.9% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, High income or Luxembourg?
- Luxembourg, at 99.0% against 93.2% in High income as of 2024.
- What is the difference in immunization, hib3 between High income and Luxembourg?
- 5.8%, with Luxembourg ahead.
- How many years of comparable data are there for High income and Luxembourg?
- 28 years are reported by both, from 1997 to 2024.
- How do High income and Luxembourg rank globally for immunization, hib3?
- High income ranks 4th and Luxembourg ranks 1st of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.